Santen Pharmaceutical Co (JP:4536) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Santen Pharmaceutical Co. has successfully repurchased over 2.2 million of its common shares, amounting to nearly 3.94 billion yen, as part of its ongoing share buyback program. This strategic move aligns with their broader plan to repurchase up to 21.11 million shares by November 6, 2024, reflecting a commitment to enhancing shareholder value.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
